Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeki Yagyu

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Pediatrics International : Official Journal of the Japan Pediatric Society|July 4, 2025
Identifying miRNAs as predictive markers of good prognosis in neuroblastomaHiroaki Kondo, Ken Kikuchi, Akimasa Tomida, et al.
Oncology Reports|February 6, 2019
[Erratum] OBP‑801, a novel histone deacetylase inhibitor, induces M‑phase arrest and apoptosis in rhabdomyosarcoma cellsChihiro Tomoyasu, Ken Kikuchi, Daisuke Kaneda, et al.
Cancer Genetics and Cytogenetics|January 22, 2008
Late appearance of a Philadelphia chromosome in a patient with therapy-related acute myeloid leukemia and high expression of EVI1Shigeki Yagyu, Akira Morimoto, Naoki Kakazu, et al.
Oncology Reports|March 3, 2023
<i>In ovo</i> chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcomaChika Shoji, Ken Kikuchi, Hideki Yoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cellsMitsuru Miyachi, Naoki Kakazu, Shigeki Yagyu, et al.
Molecular Therapy. Oncology|June 8, 2026
mRNA-LNP vaccine providing antigen and co-stimulation in the tumor microenvironment enhances CAR T cell function (CART-Vac)Ikumi Nakashima, Shoji Saito, Jingbo Zhao, et al.
Cancer Gene Therapy|October 18, 2014
Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicityMiki Ando, Valentina Hoyos, Shigeki Yagyu, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|June 21, 2022
The histone deacetylase inhibitor OBP-801 has in vitro/in vivo anti-neuroblastoma activityDaisuke Kaneda, Tomoko Iehara, Ken Kikuchi, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cellsKohei Mitsuno, Masaya Suematsu, Yuki Naito, et al.
Endocrine Journal|September 6, 2019
Pituitary apoplexy after cardiac surgery in a 14-year-old girl with Carney complex: a case reportYuki Naito, Jun Mori, Jun Tazoe, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Pediatrics International : Official Journal of the Japan Pediatric Society|July 4, 2025
Identifying miRNAs as predictive markers of good prognosis in neuroblastomaHiroaki Kondo, Ken Kikuchi, Akimasa Tomida, et al.
Oncology Reports|February 6, 2019
[Erratum] OBP‑801, a novel histone deacetylase inhibitor, induces M‑phase arrest and apoptosis in rhabdomyosarcoma cellsChihiro Tomoyasu, Ken Kikuchi, Daisuke Kaneda, et al.
Cancer Genetics and Cytogenetics|January 22, 2008
Late appearance of a Philadelphia chromosome in a patient with therapy-related acute myeloid leukemia and high expression of EVI1Shigeki Yagyu, Akira Morimoto, Naoki Kakazu, et al.
Oncology Reports|March 3, 2023
<i>In ovo</i> chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcomaChika Shoji, Ken Kikuchi, Hideki Yoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cellsMitsuru Miyachi, Naoki Kakazu, Shigeki Yagyu, et al.
Molecular Therapy. Oncology|June 8, 2026
mRNA-LNP vaccine providing antigen and co-stimulation in the tumor microenvironment enhances CAR T cell function (CART-Vac)Ikumi Nakashima, Shoji Saito, Jingbo Zhao, et al.
Cancer Gene Therapy|October 18, 2014
Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicityMiki Ando, Valentina Hoyos, Shigeki Yagyu, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|June 21, 2022
The histone deacetylase inhibitor OBP-801 has in vitro/in vivo anti-neuroblastoma activityDaisuke Kaneda, Tomoko Iehara, Ken Kikuchi, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cellsKohei Mitsuno, Masaya Suematsu, Yuki Naito, et al.
Endocrine Journal|September 6, 2019
Pituitary apoplexy after cardiac surgery in a 14-year-old girl with Carney complex: a case reportYuki Naito, Jun Mori, Jun Tazoe, et al.
Pageof 7